Cns Pharmaceuticals Inc
$1.04
(as of May 30, 9:30 AM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for Cns Pharmaceuticals Inc
Stock Price
$1.04
Ticker Symbol
CNSP
Exchange
NASDAQ
Industry Information for Cns Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Company Description for Cns Pharmaceuticals Inc
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Fundamentals for Cns Pharmaceuticals Inc
Market Capitalization
$5,844,287
EBITDA
$-15,691,161
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-924.60
Earnings per Share Estimate Next Year
Profit Margin
Shares Outstanding
5,461,950
Percent Owned by Insiders
0.21%
Percent Owned by Institutions
1.13%
52-Week High
52-Week Low
Technical Indicators for Cns Pharmaceuticals Inc
Analyst Ratings for Cns Pharmaceuticals Inc
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
News About Cns Pharmaceuticals Inc
Jan 11, 2023, 1:00 PM EST
- Live video webcast presentations with participating companies -
See more.
Oct 7, 2022, 8:00 AM EST
LOS ANGELES, Oct. See more.
Apr 13, 2022, 10:45 AM EST
- Live video webcast events on Thursday, April 14 at 10 AM ET, 11:30 AM ET and 1 PM ET -
See more.
Jan 12, 2022, 10:35 AM EST
- Access the event and schedule of presenting companies at virtualinvestorco.com -
See more.